Prognostic Utility of the Cytokine Profile for Predicting Major Adverse Cardiovascular Events in Acute Myocardial Infarction Following Percutaneous Coronary Intervention
International Journal of General Medicine · 2026-03 · Volume 19 · 1-13
DOI: 10.2147/ijgm.s595144 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of General Medicine, 2026-03. Verfasst von Juan Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Rep…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
This study aimed to assess the clinical utility and prognostic value of a panel of serum cytokines for predicting major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
Methods
We enrolled 232 AMI patients who underwent PCI. Based on the occurrence of MACE during follow-up, patients were categorized into a poor prognosis group (n=127) and a good prognosis group (n=105). Serum levels of interleukin IL-1β, IL-6, IL-8, IL-10, and tumor necrosis factor-alpha (TNF-α) were measured. Spearman correlation analysis was employed to evaluate the relationships between cytokine levels and MACE risk. Nine distinct machine learning models, incorporating all identified independent risk factors for MACE, were developed and evaluated.
Results
Levels of high-sensitivity C-reactive protein (hs-CRP), IL-6, IL-8, and TNF-α were significantly elevated in patients who developed MACE compared to those who did not. IL-6 emerged as a relatively strong predictor of MACE, with an area under the curve (AUC) of 0.82 (95% CI: 0.77-0.87). The IL-6/IL-10 ratio also demonstrated predictive value for MACE (AUC=0.74, 95% CI: 0.69-0.80). Furthermore, significant differences were observed between initial presentation and readmission levels for the IL-8/IL-10 and TNF-α/IL-10 ratios in patients readmitted for AMI following MACE. Among the nine machine learning models constructed, the XGBoost and Logistic Regression models, which incorporated all independent risk factors, demonstrated robust performance, both AUC values exceeded 0.8.
Conclusion
AMI patients with elevated serum cytokine levels exhibited a lower 1-year survival rate. Serum cytokine profiles show significant predictive value for MACE following PCI in AMI patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
- Department of Laboratory Medicine, Wuhan Asia Heart Hospital, Wuhan, Hubei, People's Republic of China.
Zitieren
APA
Yang, J., Zhang, B., Li, L., Wu, Y., & Lu, Y. (2026). Prognostic Utility of the Cytokine Profile for Predicting Major Adverse Cardiovascular Events in Acute Myocardial Infarction Following Percutaneous Coronary Intervention. International Journal of General Medicine, Volume 19, 1-13. https://doi.org/10.2147/ijgm.s595144
Vancouver
Yang J, Zhang B, Li L, Wu Y, Lu Y. Prognostic Utility of the Cytokine Profile for Predicting Major Adverse Cardiovascular Events in Acute Myocardial Infarction Following Percutaneous Coronary Intervention. International Journal of General Medicine. 2026;Volume 19:1-13. doi:10.2147/ijgm.s595144
BibTeX
@article{Yang2026,
author = {Yang, Juan and Zhang, Bo and Li, Ling and Wu, Yu and Lu, Yanjun},
title = {Prognostic Utility of the Cytokine Profile for Predicting Major Adverse Cardiovascular Events in Acute Myocardial Infarction Following Percutaneous Coronary Intervention},
journal = {International Journal of General Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--13},
doi = {10.2147/ijgm.s595144}
}
EUVIMED